ubmslateRN-logo-ubm

RN Mobile Menu

Topics:

Rheumatology Network

Beyond Zika: 7 Things Rheumatologists Should Know about Chikungunya

Cleveland Clinic's Leonard Calabrese, D.O., talks with Rheumatology Network about chikungunya, a mosquito-borne viral disease that mimics arthritis. (nechaevkon/Shutterstock.com)

Recent Content

@CreativeImages/Shutterstock.com

Research points to evidence showing that microorganisms inside our bodies could play a role in the development of arthritis, but it could also be a new therapeutic pathway.

Leonard Calabrese, D.O.

With the spread of Zika virus rating as a "public health emergency" by the World Health Organization, another emerging mosquito-borne illness is worrying rheumatologists: chikungunya.

Eric Morand, M.D., PhD.

Eric Morand, M.D., Ph.D., Director of Rheumatology at Monash Health in Australia, speaks with Rheumatology Network about his recent article in Nature Reviews Rheumatology.

@DeVisu/Shutterstock.com

Study shows that 14-3-3η protein serum levels can more accurately identify patients with early polyarthritis at risk for long-term poor outcomes.

In 2015, ACR and EULAR issued classification criteria for gout. The scoring system is summarized here in an easy to use format for physicians and patients.

@ThamKC/Shutterstock.com

Few gout patients know their serum urate goals, which researchers say could hinder their chances of reaching remission.

Seth Lederman M.D.

Profiles in Rheumatology: Seth Lederman, M.D., chairman and CEO of Tonix Pharmaceuticals

By clicking Accept, you agree to become a member of the UBM Medica Community.